全文获取类型
收费全文 | 187143篇 |
免费 | 18288篇 |
国内免费 | 11889篇 |
专业分类
耳鼻咽喉 | 1724篇 |
儿科学 | 2060篇 |
妇产科学 | 2590篇 |
基础医学 | 22987篇 |
口腔科学 | 3373篇 |
临床医学 | 24351篇 |
内科学 | 26670篇 |
皮肤病学 | 2592篇 |
神经病学 | 9803篇 |
特种医学 | 6860篇 |
外国民族医学 | 103篇 |
外科学 | 19013篇 |
综合类 | 30145篇 |
现状与发展 | 40篇 |
一般理论 | 25篇 |
预防医学 | 12224篇 |
眼科学 | 4964篇 |
药学 | 20633篇 |
189篇 | |
中国医学 | 11317篇 |
肿瘤学 | 15657篇 |
出版年
2024年 | 458篇 |
2023年 | 2742篇 |
2022年 | 4745篇 |
2021年 | 9971篇 |
2020年 | 7540篇 |
2019年 | 6582篇 |
2018年 | 6937篇 |
2017年 | 6355篇 |
2016年 | 6035篇 |
2015年 | 9220篇 |
2014年 | 11201篇 |
2013年 | 10334篇 |
2012年 | 15169篇 |
2011年 | 16245篇 |
2010年 | 10319篇 |
2009年 | 7982篇 |
2008年 | 10590篇 |
2007年 | 10005篇 |
2006年 | 9512篇 |
2005年 | 9254篇 |
2004年 | 5975篇 |
2003年 | 5427篇 |
2002年 | 4474篇 |
2001年 | 3716篇 |
2000年 | 3914篇 |
1999年 | 3984篇 |
1998年 | 2355篇 |
1997年 | 2406篇 |
1996年 | 1834篇 |
1995年 | 1790篇 |
1994年 | 1546篇 |
1993年 | 936篇 |
1992年 | 1330篇 |
1991年 | 1150篇 |
1990年 | 926篇 |
1989年 | 865篇 |
1988年 | 783篇 |
1987年 | 628篇 |
1986年 | 465篇 |
1985年 | 411篇 |
1984年 | 195篇 |
1983年 | 170篇 |
1982年 | 99篇 |
1981年 | 127篇 |
1980年 | 81篇 |
1979年 | 116篇 |
1978年 | 55篇 |
1977年 | 53篇 |
1976年 | 44篇 |
1974年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
991.
红藻氨酸作用后海马神经元胞膜表面的超微结构的原子力显微镜观察 总被引:4,自引:0,他引:4
目的 观察原代培养神经元在红藻氨酸(KA)作用下细胞表面形态的三维构像变化。方法 利用原子力显微镜(AFM)对大鼠海马神经元经不同浓度的KA(25和250μmol/L,50和100nmol/L)分别作用10min和100min后的表面结构进行纳米级水平扫描和观测。结果 正常海马神经元表面光滑,起伏均匀、规律;KA作用后神经元呈退行性改变,表现为胞体肿胀,胞膜表面粗糙,出现隆起和“孔洞”样结构,并且其变化程度分别与作用时问和KA浓度呈量-效关系。结论 KA对海马神经元毒性作用后胞膜表面超微结构所产生的明显变化,可借助AFM清晰观察,并定量分析。 相似文献
992.
Ming Yang Chang Emma Parker Salwa Ibrahim John R Shortland Meguid El Nahas John L Haylor Albert C M Ong 《Nephrology, dialysis, transplantation》2006,21(8):2078-2084
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited human kidney disease and is caused by germline mutations in PKD1 (85%) or PKD2 (15%). It has been estimated that around 1% of tubular cells give rise to cysts, and cell hyperproliferation has been noted to be a cardinal feature of cystic epithelium. Nevertheless, it is uncertain whether the increase in proliferative index observed is an early or late feature of the cystic ADPKD kidney. METHODS: Two Pkd2 mouse mutants (WS25 and WS183) have been recently generated as orthologous models of PKD2. To determine the effect of Pkd2 dosage on cell proliferation, cyst formation and renal fibrosis, we studied renal tissue from Pkd2(WS25/WS25) and Pkd2(+/-) mice by histological analysis. We also examined the proliferative index in archival nephrectomy tissue obtained from patients with ADPKD and normal controls. RESULTS: The proliferative index of non-cystic tubules in Pkd2 mutant mice as assessed by proliferating cell nuclear antigen and Ki67-positive nuclei was between 1-2%, values 5-10 times higher than control tissue. Similarly, the proliferative index of non-cystic tubules in human ADPKD kidneys was 40 times higher than corresponding controls. In Pkd2 mutant mice, significant correlations were found between the fibrosis score and the mean cyst area as well as with the proliferative index. Of significance, proliferating tubular cells were uniformly positive for polycystin-2 expression in Pkd2(+/-) kidney. CONCLUSION: These results suggest that an increase in cell proliferation is an early event preceding cyst formation and can result from haploinsufficiency at Pkd2. The possible pathogenic link between tubular cell proliferation, interstitial fibrosis and cyst formation is discussed. 相似文献
993.
Shang Wen Chen Ji An Liang Shih Neng Yang Hui Ling Ko Fang Jen Lin 《Radiotherapy and oncology》2003,67(1):69-76
BACKGROUND AND PURPOSE: The potential risk of prolongation of treatment time in cervical cancer has been reported for many low-dose rate (LDR) studies, with an estimated loss of local control ranging from 0.3 to 1.6% per day of treatment prolongation. Since the treatment schedule for fractionated high-dose rate intracavitary brachytherapy (HDRICB) is not directly comparable with that for low-dose rate studies, this report aims to evaluate the adverse effect of treatment prolongation specifically for cervical cancer treated with HDRICB. MATERIAL AND METHODS: From September 1992 to December 1997, 257 patients diagnosed with uterine cervical cancer (35 Ib, 26 IIa, 122 IIb, 10 IIIa, 57 IIIb, 7 IVa), who underwent external radiotherapy combined with between two and four courses of HDRICB and a minimum of 3 years of follow-up (median 57 months), were analyzed. Treatment consisted of irradiation of the whole pelvis with 44-45 Gy consisting of 22-25 fractions by 5 weeks, with the dose boosted to 54-58 Gy (with central shielding) for patients diagnosed as FIGO stage IIb-IVa bilateral parametrial disease. HDRICB was performed using an Ir-192 remote afterloading technique at 1-week intervals. The standard prescribed dose for each course of HDRICB was 7.2 Gy to point A for three insertions (before July 1995), or 6.0 Gy to point A for four insertions (after July 1995). Total prescribed point A doses (external beam radiotherapy+HDRICB) ranged from 58 to 71.6 Gy (median, 65.6 Gy) for stage IB-IIA, while analogous dosage for larger lesions (stage IIb-IVa) ranged from 59 to 75.6 Gy (median, 65.6 Gy). Kaplan-Meier and multivariate analyses were used to test the effect of treatment time on pelvic control rate (PCR) and cause-specific survival (CSS) at 5 years. RESULTS: Median treatment time was 63 days. For all stages of disease, the 5-year CSS and PCR were significantly different comparing treatment times of less than and greater than or equal to 63 days [83% and 65% (P=0.004], 93% and 83% (P=0.02), respectively]. These associations were also significant for stage Ib/IIa [97% and 79% (P=0.01), and 100% and 87% (P=0.02), respectively), but not for stage IIb [75% and 72% (P=0.79), and 93% and 87% (P=0.83), respectively] or stage III [66% and 49% (P=0.2), and 83% and 72% (P=0.21), respectively]. Multivariate analysis identified three prognostic factors for CSS, stage (P<0.001), tumor response to external RT (P=0.001), and overall treatment time (OTT; P=0.006). Prognostic factors for pelvic failure were stage (P<0.001), tumor response to external RT (P=0.001), and OTT (P=0.03). Prolongation of treatment time resulted in a daily decrease in pelvic control rate of 0.67% overall, and 0.43% for stage Ib-IIa, 0.57% for stage IIb, and 0.73% for stage III patients. CONCLUSION: Analysis of the data from the current study demonstrates that the adverse effect of treatment prolongation was observed later in the treatment course for the high-dose rate (HDR) series compared to the LDR analog, however, treatment-time prolongation still negatively influenced the cause-specific survival and pelvic control rate for both dosage groups. 相似文献
994.
医疗人才的竞争已经形成。医疗人才由著名大医院流向中外合资合作医疗机构的局面已经出现。这是一个开放的时代。每个人都有选择自己职业、生活的权利。 相似文献
995.
Diffuse pulmonary hemorrhage leading to death is a syndrome which may develop in leptospirosis, but its pathophysiology is not well documented. We report an autopsy case of leptospirosis. A healthy 41-year-old man presented with low back myalgia, dry cough and fever for 4 days and a normal chest X-ray on admission. Acute respiratory failure developed hours later. Profuse bloody fluid appeared in the endotracheal tube immediately after intubation. Chest X-ray showed whiteness across all lung fields. He died of persistent shock 16 h after the onset of acute respiratory failure. Autopsy revealed diffuse pulmonary hemorrhage with hyaline-membrane formation, myocarditis, interstitial nephritis and hepatitis. Silver stain of lung and kidney tissue demonstrated leptospires. Immunohistochemical staining showed inducible nitric oxide synthase in alveolar macrophages. Immunofluorescein staining showed immunoglobulin in alveolar septum and alveolar space. This case suggests that hemorrhagic diffuse alveolar damage with persistent shock is related to over-production of nitric oxide and immunoglobulin deposition in fatal leptospirosis. 相似文献
996.
应用蛋白质组学技术在人肾癌组织中发现2个特异性生物标志物 总被引:3,自引:0,他引:3
目的探讨人肾肿瘤组织和正常肾组织之间蛋白质的差异表达,寻找特异性生物标记物。方法应用蛋白质组学(SELDI)技术,检测12例人肾肿瘤和正常肾组织蛋白质谱图表达。结果与正常肾组织比较,在IMAC3蛋白质芯片上人肾肿瘤组织谱图中显示2个特异性蛋白质峰明显增高,相对分子质量依次为5750.4和5861.7,其特异性和敏感性高。结论人肾肿瘤组织中特异性蛋白质的发现,对进一步研究肿瘤发生机理及其临床特异性生物标志物的检测等具有重要意义。 相似文献
997.
重组骨形态发生蛋白-2结合软骨下钻孔治疗犬关节软骨全层缺损的实验研究 总被引:3,自引:0,他引:3
目的 研究重组骨形态发生蛋白-2(rhBMP-2)结合软骨下骨钻孔治疗犬关节软骨全层缺损的可行性,为临床应用提供实验依据。方法 依照软骨缺损处理方法的不同将64侧股骨髁随机均分为4组:①结合组:软骨下骨钻孔 胶原海绵吸附rhBMP-2充填软骨缺损;②BMP组:胶原海绵吸附rhBMP-2充填软骨缺损;③钻孔组:单纯软骨下骨钻孔;④对照组:不作处理或单纯用胶原海绵填塞。术后2、4、8、12周取材观察其大体、光镜、透射电镜、免疫组织化学情况。结果 除对照组仅有纤维组织修复外,其余3组均有不同程度的软骨修复,但结合组的修复在组织细胞形态、超微结构、Ⅱ型胶原含量等方面均明显优于其他两组。结论rhBMP-2结合软骨下骨钻孔能有效修复犬膝关节软骨的全层缺损,该技术可行,有望在临床应用。 相似文献
998.
组织工程支架在犬急性脊髓损伤修复中应用的初步研究 总被引:6,自引:1,他引:5
目的探讨携带神经干细胞的聚碳酸亚丙酯[poly(propylene carbonate),PPC]可降解支架移植在犬脊髓急性损伤后修复中的作用。方法制作犬T13脊髓左侧半切损伤模型。将实验动物随机分为3组:细胞支架组在损伤后1周时将填充神经干细胞的PPC可降解支架植入损伤区.支架组只植入支架,对照组不作移植。8周后观察支架的组织反应、降解情况及神经干细胞的迁移分化和脊髓轴突再生情况。结果支架部分降解,管腔内未见瘢痕侵入。神经干细胞向支架邻近部位广泛迁移、扩散,并分化为3种神经细胞表型。神经丝蛋白(NF)及髓鞘碱性磷酯蛋白(MBP)免疫组化显示细胞支架组脊髓损伤区邻近部位的继发损害较其他组轻。结论携带神经干细胞的PPC可降解支架在犬脊髓组织中无明显组织反应.能够抵御瘢痕侵入:其携带的神经干细胞能够整合入邻近脊髓组织并起到一定保护作用。 相似文献
999.
镁离子对大鼠弥漫性轴索损伤超微结构的影响 总被引:1,自引:0,他引:1
目的探讨镁离子(Mg^2 )对脑弥漫性轴索损伤(diffuse axonal injury,DAI)脑干超微结构的影响。方法选健康成年雄性SD大鼠36只,体重350~450g,将其随机分为实验组、对照组、空白组,每组为12只。采用改良Marmarou模型制作DAI模型,伤后30min分别给予MgSO4 250μmol/kg、等渗盐水0.2ml,伤后24h处死。用透射电镜分别检测脑干超微结构,并行综合组织损伤评分。结果伤后24h,对照组髓鞘分离,线粒体嵴明显肿胀;实验组未见髓鞘分离,线粒体轻度肿胀。实验组脑干综合组织损伤程度评分明显轻于对照组。结论Mg^2 可在超微结构水平阻止DAI轴索的继发性损害,对DAI具有一定的保护作用。 相似文献
1000.
自2003年7月-2005年2月,笔者采用中西医结合方法治疗特发性面神经麻痹32例,疗效显著,报告如下。 相似文献